Industrial Seminar Series: Illumina + Fortrea

Join Illumina and Fortrea in this upcoming seminar (code-shared with SP2401) on a learning journey into rare diseases diagnosis and intervention. Hear from Fortrea, a leading clinical research organization, on characteristics and challenges in development of therapeutics for rare diseases. Illumina, a world-leading authority in deep sequencing, will illuminate how they integrated platforms plays a critical role in mapping rare diseases genotypes.